Should the U.S. adopt Denmark's vaccine policy? It's a complex question, and experts have differing opinions. While Denmark recommends routine vaccination against just 10 diseases, the U.S. currently schedules 16 diseases, with a recent reduction to 17. But there's more to consider than just the number of diseases. Denmark's population is much smaller, with around 6 million people, compared to the U.S.'s 343 million. This difference in scale alone makes direct comparison challenging. Denmark's highly unified health system, with a national registry, allows for efficient disease tracking and management. In contrast, the U.S. struggles with fragmented insurance, high uninsured rates, and gaps in care continuity. These disparities in healthcare access and infrastructure significantly influence vaccine recommendations. The U.S. prioritizes disease prevention, while Denmark focuses on management. This shift in focus could potentially leave U.S. children more vulnerable to certain diseases. The controversy lies in whether scaling back the U.S. vaccine schedule to match Denmark's is a wise move. Critics argue that it's like comparing a cruise ship to a kayak, highlighting the need for context-specific approaches. The U.S. is not an outlier in vaccination recommendations; rather, Denmark stands out for its minimalism. The legal process for vaccine policy changes is also murky, raising questions about the Trump administration's potential actions.
